Trials / Unknown
UnknownNCT06609525
Comparing Efficacy and Safety of CTO0303 in Pediatric Subjects
A Multi-center, Double-blind, Randomized, Parallel, Active-controlled, Non-inferior, Phase Ⅱb/Ⅲ Study to Evaluate the Safety and Efficacy of CTO0303
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 156 (estimated)
- Sponsor
- Taejoon Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 4 Years – 15 Years
- Healthy volunteers
- Accepted
Summary
This is a prospective randomized study compared with active control arm.
Detailed description
This is a prospective randomized study compared with active control arm. The investigators compare the pupil size in subject when 30 minutes after administering IP (CTO0303 or active control).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CTO0303-A | eye drop, 1 drop 3 times (every 5 minutes) a day |
| DRUG | CTO0303-B | eye drop, 1 drop 3 times (every 5 minutes) a day |
| DRUG | CTO0303-C | eye drop, 1 drop 3 times (every 5 minutes) a day |
Timeline
- Start date
- 2024-05-09
- Primary completion
- 2024-12-31
- Completion
- 2025-03-01
- First posted
- 2024-09-24
- Last updated
- 2024-09-24
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06609525. Inclusion in this directory is not an endorsement.